This domain addresses a risk-based lifecycle approach for evaluating GMP-relevant systems and equipment through structured risk assessment, periodic performance review, and evidence-based requalification decisions. Content focuses on using risk and operational trend data to define requalification scope and intervals commensurate with system criticality, performance history, and regulatory expectations.
Content in this category includes methodologies for risk assessment and analysis, fault and failure analysis techniques, and the practical use of risk management to support validation planning, execution, and lifecycle decision-making.
Risk-Based Requalification is a structured, documented process used to determine when requalification is required, to what extent it should be performed, and at what interval, based on risk and objective performance evidence. Unlike calendar-driven requalification programs, a risk-based approach ensures that requalification activities are commensurate with equipment criticality, historical performance, and demonstrated state of control….
Periodic Equipment Assessment is a structured, documented review performed to confirm that GMP-relevant equipment, systems, and utilities remain fit for their intended use and continue to operate in a state of control following initial qualification. Unlike initial validation, which establishes fitness for use, periodic assessment evaluates ongoing performance, emerging risks, and the continued adequacy of…
Risk Assessment is a structured evaluation of potential failure modes associated with GMP-relevant systems, equipment, utilities, and processes that may impact product quality, patient safety, data integrity, or regulatory compliance. Within a validation lifecycle, risk assessment is used to define validation scope, testing depth, and control strategy, ensuring that validation effort is proportionate to system…
Failure Tree Analysis (commonly referred to as Fault Tree Analysis, FTA) is a structured risk analysis technique used to evaluate how combinations of failures can lead to a defined undesired event. In regulated pharmaceutical and medical device environments, FTA is typically applied to complex systems, high-risk processes, or scenarios where a single failure mode does…
The risk-based approach to validation is a structured methodology used to define validation scope, depth, and rigor based on the potential impact of systems, equipment, and processes on product quality, patient safety, and regulatory compliance. This approach recognizes that not all systems and activities present the same level of risk and that validation effort should…
